@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:10516_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii."@en, "Antibiótico macrólido producido por Streptomyces ambofaciens. El fármaco es eficaz contra bacterias gram-positivas de patógenos aerobios, N. gonorrhoeae y los estafilococos. Se utiliza para tratar infecciones causadas por bacterias y Toxoplasma gondii."@es ;
  dc:source "Medical Subject Headings 2011" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:10516
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2006-01-19"^^xsd:date ;
  dc:modified "2013-09-05"^^xsd:date ;
  skos:broader nalt:148770, nalt:3055 ;
  skos:definition nalt:10516_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "espiramicina"@es, "spiramycin"@en ;
  ns0:marc001 "34864" .

nalt:148770
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:10516 ;
  skos:prefLabel "leucomycins"@en, "leucomicinas"@es .

nalt:3055
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:10516 ;
  skos:prefLabel "agentes antiprotozoicos"@es, "antiprotozoal agents"@en .